Haleos Labs Limi

{
  "main_header": {
    "sid": 1002809,
    "name": "Haleos Labs Limi",
    "stock_name": "Haleos Labs Limi",
    "full_name": "Haleos Labs Limited",
    "name_url": "stocks-analysis/haleos-labs-limi",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,318.00",
    "chg": -33,
    "chgp": "-2.44%",
    "dir": -1,
    "prev_price": "1,351.00",
    "mcapval": "393.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540679,
    "symbol": "HALEOSLABS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE320X01016",
    "curr_date": "Feb 11",
    "curr_time": "",
    "bse_nse_vol": "508 ",
    "exc_status": "Active",
    "traded_date": "Feb 11, 2026",
    "traded_date_str": "2026 02 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/haleos-labs-limi-1002809-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Haleos Labs Limited?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-haleos-labs-limited-3823252",
        "imagepath": "",
        "date": "2026-02-05 23:18:32",
        "description": "Haleos Labs Limited is scheduled to declare its results on 11 February 2026...."
      },
      {
        "title": "Haleos Labs Limited Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-financials-3817395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HaleosLabsLimit_mojoScore_3817395.png",
        "date": "2026-02-03 08:21:02",
        "description": "Haleos Labs Limited has seen its investment rating upgraded from Sell to Hold as of 2 February 2026, reflecting a notable improvement in its technical indicators and valuation metrics. Despite lingering concerns over long-term fundamentals, recent quarterly financial performance and a shift in market sentiment have contributed to a more balanced outlook for this pharmaceuticals and biotechnology company."
      },
      {
        "title": "Haleos Labs Limited Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/haleos-labs-limited-hits-upper-circuit-amid-strong-buying-pressure-3814729",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HaleosLabsLimit_stocks_hitting_upper_circuit_3814729.png",
        "date": "2026-02-01 14:00:10",
        "description": "Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 1 Feb 2026, closing at ₹1240.0, marking a maximum daily gain of 4.91%. This sharp rally was driven by robust buying interest despite subdued trading volumes and a regulatory freeze on further price movement, reflecting strong investor sentiment amid sector headwinds."
      },
      {
        "title": "Haleos Labs Limited is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-hold-3804016",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/HaleosLabsLimit_mojoScore_3804016.png",
        "date": "2026-01-25 10:10:30",
        "description": "Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Haleos Labs Limited is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-hold-by-marketsmojo-3791805",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/HaleosLabsLimit_mojoScore_3791805.png",
        "date": "2026-01-14 10:10:37",
        "description": "Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Haleos Labs Limited is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-hold-by-marketsmojo-3779920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/HaleosLabsLimit_mojoScore_3779920.png",
        "date": "2026-01-03 10:10:34",
        "description": "Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Haleos Labs Limited Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/haleos-labs-limited-hits-lower-circuit-amid-heavy-selling-pressure-3770563",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/HaleosLabsLimit_stocks_hitting_lower_circuit_3770563.png",
        "date": "2025-12-26 11:00:15",
        "description": "Shares of Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 26 Dec 2025, hitting the lower circuit limit and registering one of the steepest single-day declines in recent times. The stock’s performance contrasted sharply with broader market indices and its sector peers, reflecting a wave of panic selling and unfilled supply on the trading floor."
      },
      {
        "title": "Haleos Labs Limi Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limi-upgraded-from-sell-to-hold-by-marketsmojo-on-1-dec-2025-3766973",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/HaleosLabsLimi_mojoScore_3766973.png",
        "date": "2025-12-23 10:10:29",
        "description": "Haleos Labs Limi has undergone a revision in its market evaluation, reflecting a shift in analytical perspective driven by recent financial developments and valuation considerations. The pharmaceutical and biotechnology company’s assessment now indicates a more balanced outlook, influenced by changes across quality, valuation, financial trends, and technical factors."
      },
      {
        "title": "Haleos Labs Limited Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/haleos-labs-limited-hits-lower-circuit-amid-heavy-selling-pressure-3762776",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/HaleosLabsLimit_stocks_hitting_lower_circuit_3762776.png",
        "date": "2025-12-18 15:00:10",
        "description": "Shares of Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 18 Dec 2025, hitting the lower circuit limit and registering a maximum daily loss of 5.0%. The stock closed at ₹1,232.4, marking a significant decline amid subdued investor participation and unfilled supply on the order books."
      }
    ],
    "total": 427,
    "sid": "1002809",
    "stock_news_url": "https://www.marketsmojo.com/news/haleos-labs-limited-1002809"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for 96Th Board Meeting (11.02.2026)",
      "datetime": "04-Feb-2026",
      "details": "Haleos Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Unaudited financial results (Standalone and Consolidated) of the Company for the quarter and nine months ended 31/12/2025 and any other item as may be decided by the Board of Directors.",
      "source": "BSE"
    },
    {
      "caption": "Collaboration (HRV Global)",
      "datetime": "21-Jan-2026",
      "details": "Company has entered into Stategic Development collabration with HRV Global Life Sciences Private Limited and will make further disclosure as and when there is any material update on the same.",
      "source": "BSE"
    },
    {
      "caption": "Report (Special Window)",
      "datetime": "13-Jan-2026",
      "details": "Enclosed summary from December 1 2025 to January 6 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Haleos Labs Limited has declared <strong>15%</strong> dividend, ex-date: 24 Sep 25",
          "dt": "2025-09-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

When is the next results date for Haleos Labs Limited?

2026-02-05 23:18:32

Haleos Labs Limited is scheduled to declare its results on 11 February 2026....

Read full news article

Haleos Labs Limited Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials

2026-02-03 08:21:02

Haleos Labs Limited has seen its investment rating upgraded from Sell to Hold as of 2 February 2026, reflecting a notable improvement in its technical indicators and valuation metrics. Despite lingering concerns over long-term fundamentals, recent quarterly financial performance and a shift in market sentiment have contributed to a more balanced outlook for this pharmaceuticals and biotechnology company.

Read full news article

Haleos Labs Limited Hits Upper Circuit Amid Strong Buying Pressure

2026-02-01 14:00:10

Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 1 Feb 2026, closing at ₹1240.0, marking a maximum daily gain of 4.91%. This sharp rally was driven by robust buying interest despite subdued trading volumes and a regulatory freeze on further price movement, reflecting strong investor sentiment amid sector headwinds.

Read full news article

Haleos Labs Limited is Rated Hold

2026-01-25 10:10:30

Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Haleos Labs Limited is Rated Hold by MarketsMOJO

2026-01-14 10:10:37

Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Haleos Labs Limited is Rated Hold by MarketsMOJO

2026-01-03 10:10:34

Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Haleos Labs Limited Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-26 11:00:15

Shares of Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 26 Dec 2025, hitting the lower circuit limit and registering one of the steepest single-day declines in recent times. The stock’s performance contrasted sharply with broader market indices and its sector peers, reflecting a wave of panic selling and unfilled supply on the trading floor.

Read full news article

Haleos Labs Limi Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-23 10:10:29

Haleos Labs Limi has undergone a revision in its market evaluation, reflecting a shift in analytical perspective driven by recent financial developments and valuation considerations. The pharmaceutical and biotechnology company’s assessment now indicates a more balanced outlook, influenced by changes across quality, valuation, financial trends, and technical factors.

Read full news article

Haleos Labs Limited Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-18 15:00:10

Shares of Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 18 Dec 2025, hitting the lower circuit limit and registering a maximum daily loss of 5.0%. The stock closed at ₹1,232.4, marking a significant decline amid subdued investor participation and unfilled supply on the order books.

Read full news article

View All News